tariquidar has been researched along with nutlin-3a in 2 studies
| Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) | Studies (nutlin-3a) | Trials (nutlin-3a) | Recent Studies (post-2010) (nutlin-3a) |
|---|---|---|---|---|---|
| 210 | 16 | 138 | 698 | 1 | 504 |
| Protein | Taxonomy | tariquidar (IC50) | nutlin-3a (IC50) |
|---|---|---|---|
| Protein Mdm4 | Homo sapiens (human) | 4.6273 | |
| Cellular tumor antigen p53 | Homo sapiens (human) | 1.0388 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.07 | |
| E3 ubiquitin-protein ligase Mdm2 | Homo sapiens (human) | 0.1832 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grigoreva, T; Novikova, D; Romanova, A; Sagaidak, A; Tribulovich, V; Vorona, S | 1 |
| Garabadzhiu, A; Grigoreva, T; Novikova, D; Romanova, A; Sagaidak, A; Tribulovich, V | 1 |
2 other study(ies) available for tariquidar and nutlin-3a
| Article | Year |
|---|---|
Mdm2 inhibitors as a platform for the design of P-glycoprotein inhibitors.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Computer Simulation; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Isatin; Models, Molecular; Piperazines; Protein Binding; Proto-Oncogene Proteins c-mdm2; Quinolines; Structure-Activity Relationship | 2020 |
Establishment of drug-resistant cell lines under the treatment with chemicals acting through different mechanisms.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Drug Resistance, Neoplasm; Enzyme Inhibitors; HCT116 Cells; Humans; Imidazoles; Paclitaxel; Piperazines; Proto-Oncogene Proteins c-mdm2; Quinolines; Vanadates | 2021 |